NAD Therapy: What It Is, What the Evidence Shows, and What to Know Before Trying It

NAD therapy refers to treatment intended to raise nicotinamide adenine dinucleotide, a coenzyme involved in cellular energy, DNA repair, and stress-response pathways. Human evidence is still limited and does not prove longer lifespan. NAD+ is not like Ozempic; it is not a GLP-1 weight-loss medication.

What is NAD therapy?

NAD therapy means using a product meant to raise nicotinamide adenine dinucleotide in the body. In clinics, the phrase may refer to NAD+ injection, NAD+ nasal spray, IV NAD+, NADH, or oral NAD precursors such as nicotinamide riboside and nicotinamide mononucleotide.

NAD is not a hormone and not a stimulant. It is a coenzyme your cells use to move electrons during energy production. This matters because mitochondria use electron flow to help make ATP, the usable energy currency of the cell 1.

What NAD and NAD+ do in the body

NAD+ helps enzymes run reactions tied to oxidative phosphorylation, ATP production, DNA repair, calcium-dependent signaling, and gene expression 1. It is also used by enzyme families often discussed in longevity research, including sirtuins and PARPs 3.

How NAD+ and NADH are related

NAD+ and NADH are two forms of the same molecule. NAD+ accepts electrons, and NADH carries electrons. This back-and-forth shuttle helps cells turn food into usable energy 1.

Why NAD is discussed in longevity research

NAD+ levels and NAD-related pathways change with age in many tissues, which is why NAD is studied in aging biology 3. But a pathway changing with age is not the same as proving that a treatment makes humans live longer.

What quick facts should you know about NAD therapy?

NAD therapy sits in a different category from GLP-1 weight-loss medications and from simple vitamin pills. The most useful way to think about it is as an early-stage longevity and cellular-health intervention with real biology, limited human outcomes data, and important quality-control questions.

• NAD is not Ozempic or a GLP-1. Ozempic and Wegovy contain semaglutide, a GLP-1 receptor agonist, while NAD+ is a cellular coenzyme 5.
• NAD is related to vitamin B3, but it is not simply a vitamin B3 pill. The body can make NAD from niacin, nicotinamide, nicotinamide riboside, nicotinamide mononucleotide, and tryptophan through different pathways 1.
• Human clinical evidence is early and mixed. A systematic review found 10 randomized trials with 489 total participants across several conditions 2.
• Compounded NAD+ is not FDA-approved. Sterile compounding quality matters because FDA has warned about food-grade NAD+ ingredients being used in injectable products 4.
• Route matters. NAD+ injection, nasal spray, IV infusion, NADH, and oral precursors are not identical products and should not be assumed to have the same effects.

What does NAD therapy claim to help with?

NAD therapy is often marketed for energy, fatigue, metabolic health, brain health, and aging. The biology is plausible, but the human evidence does not support broad promises or guaranteed results.

Cellular energy and mitochondrial function

Mechanistically, NAD+ is central to mitochondrial energy production. Mitochondria use NADH-derived electrons during oxidative phosphorylation to help generate ATP 1. That is a real cellular role, but it does not prove that every person will feel more energy from NAD therapy.

Fatigue and quality-of-life claims

Human randomized trials have studied NADH or NAD-related products in chronic fatigue syndrome and other groups. In a systematic review, some studies reported changes in quality of life, fatigue intensity, or sleep quality, but the studies were small and varied in design 2.

Metabolic health research

Some human trials of NAD precursors have looked at overweight, prediabetes, insulin signaling, and muscle insulin sensitivity 2. For example, a randomized trial in postmenopausal women with prediabetes reported that nicotinamide mononucleotide improved muscle insulin sensitivity, but this does not make NAD therapy a diabetes treatment or weight-loss medication 7.

Brain health and neurodegenerative disease research

NAD-related interventions have been studied in Parkinson’s disease and Alzheimer’s disease, but evidence is not strong enough to claim benefit for these conditions 2. NAD+ is not a substitute for proven care for neurodegenerative disease.

Aging and longevity claims

Animal and cell studies connect NAD pathways with aging biology, DNA repair, sirtuins, PARPs, and cellular stress response 3. Human studies have not shown that NAD therapy extends lifespan, and individual results vary.

What does human evidence actually show?

Human NAD evidence is active but still early. The best summary is that NADH and NAD precursor studies show some signals in certain measures, but not enough proof for broad disease or longevity claims.

A systematic review of randomized clinical trials found 10 studies with 489 participants. The studied groups included chronic fatigue syndrome, older adults, Parkinson’s disease, overweight, postmenopausal prediabetes, and Alzheimer’s disease 2.

The review reported that NADH and precursor supplementation was generally well tolerated in these trials. Reported side effects included muscle pain, nervous-system symptoms, fatigue, sleep disturbance, and headache 2.

Some trials reported changes in anxiety measures, maximum heart rate after stress testing, inflammatory markers, muscle insulin sensitivity, insulin signaling, quality of life, fatigue intensity, or sleep quality 2. These are not the same as proven disease treatment, proven weight loss, or proven lifespan extension.

Why biomarkers do not prove clinical benefit

A biomarker is a measurable signal, such as an inflammatory marker or a change in NAD-related metabolites. Biomarkers can help researchers understand biology, but they do not always predict how a person feels, functions, or ages over time 3.

How strong is the longevity evidence for NAD?

NAD longevity research is strongest at the mechanism and preclinical level, and weaker at the human outcomes level. That does not make the science meaningless, but it does mean the claims need limits.

Human clinical evidence

Human trials have tested NADH and NAD precursors for selected conditions and biomarkers, not for definitive human lifespan extension 2. Reviews of therapeutic NAD targeting emphasize unresolved questions about long-term safety, clinical relevance, tissue-specific effects, and which patients may benefit 3, 8.

Human observational evidence

Human observational work can support the idea that NAD biology is linked to aging and metabolic health. But observational evidence cannot prove that taking or using NAD+ causes better health outcomes 3.

Animal and cell evidence

Animal and cell studies help explain how NAD may affect mitochondrial function, DNA repair, sirtuins, PARPs, and cellular stress response 3. These models are useful for discovery, but they should not be read as proof that NAD therapy extends human lifespan.

Is NAD like Ozempic?

NAD+ is not like Ozempic. Ozempic contains semaglutide, a GLP-1 receptor agonist, while NAD+ is a coenzyme involved in cellular energy and repair pathways 1, 5.

This matters if your main goal is weight loss or blood-sugar improvement. GLP-1 medications are evaluated through a different clinical lens than NAD+ and may require a specific obesity or metabolic-health evaluation.

At Chia, we offer compounded semaglutide via 503A pharmacy as an injection and compounded tirzepatide via 503A pharmacy as tablets or injection, when prescribed by a licensed provider. Tirzepatide is a dual GIP/GLP-1 receptor agonist; semaglutide is a GLP-1 receptor agonist 5, 6.

Is NAD just vitamin B3?

NAD is related to vitamin B3, but NAD therapy is not the same thing as taking a standard vitamin pill. Your body can make NAD from several precursors, and each route and formulation has different evidence.

Niacin and nicotinamide are forms of vitamin B3. Nicotinamide riboside, nicotinamide mononucleotide, and tryptophan can also feed NAD-related pathways 1.

Oral precursors, NADH products, NAD+ injections, nasal sprays, and IV infusions should not be treated as interchangeable. A study of one precursor in one group does not prove the same result for another product or route 2.

What are the possible downsides of NAD therapy?

NAD therapy can cause side effects, and sterile injectable quality is a real safety issue. The risk profile depends on route, ingredients, dose, medical history, and pharmacy standards.

Side effects reported in human studies

In randomized trials included in a systematic review, NADH and precursor products were generally well tolerated, but side effects included muscle pain, nervous-system symptoms, fatigue, sleep disturbance, and headache 2.

FDA safety concerns about sterile compounded NAD+ injectables

FDA has warned compounders not to use food-grade NAD+ ingredients for sterile injectable drugs because inappropriate ingredients can carry contamination and endotoxin risks 4. FDA also reported adverse events after NAD+ injectable drugs, including severe chills, shaking, vomiting, and fatigue, with some cases needing medical treatment; FDA described these reactions as consistent with excessive endotoxin levels 4.

Why clinician review matters

A clinician should review your medical history, medication list, pregnancy status when relevant, allergies, goals, and safety factors before NAD+ use. NAD+ should not replace proven treatment for obesity, diabetes, substance use disorder, chronic fatigue syndrome, Parkinson’s disease, Alzheimer’s disease, or any diagnosed condition.

How much does NAD therapy cost?

NAD therapy cost varies by route, visit model, pharmacy standards, and whether the product is bundled with other care. IV clinic pricing, injections, nasal sprays, and online clinician-reviewed care are often priced differently.

At Chia, NAD+ plans currently start at $179/month for injection and $119/month for nasal spray. Product pages show the most up-to-date pricing.

• Ask whether a licensed clinician reviews eligibility before treatment.
• Ask whether sterile products come from a state-licensed 503A compounding pharmacy.
• Ask whether the pharmacy uses ingredients appropriate for sterile compounding.
• Ask what support exists if side effects occur.
• Be cautious with no-prescription products sold as research chemicals or supplements for injection.

NAD+ therapy at Chia: injections or nasal spray

NAD+ at Chia is available as injection or nasal spray after a 100% online health questionnaire and review by a licensed US provider. Prescribing is based on clinical appropriateness and is never guaranteed.

When prescribed, medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door. Dosing is provider-guided and adjusted over time, and patients can message the care team through the portal.

We keep the safety focus on the licensed path: clinician evaluation, state-licensed 503A pharmacy compounding, and follow-up support. That is different from self-directed dosing or no-prescription research-chemical sources.

How should patients think about NAD therapy before trying it?

NAD therapy is best approached with realistic expectations. It may be reasonable to discuss as part of a longevity or cellular-health plan, but it should not be framed as a proven anti-aging treatment.

1. 1Set a clear goal, such as energy, recovery, or a broader longevity plan, and ask how success will be measured.
2. 2Do not assume animal, cell, or biomarker findings prove human benefit.
3. 3Do not use NAD+ instead of proven care for diagnosed medical conditions.
4. 4Use a licensed provider rather than creating your own dosing plan.
5. 5For sterile injectable products, ask about pharmacy standards, ingredient suitability, and adverse-event support.

FAQ

Keep reading

Longevity

Nicotinamide Adenine Dinucleotide Injection: Uses, Evidence, Safety, and Cost

Longevity

NAD+ and Peptides: What They Are, How They Differ, and What They Do

Longevity

NAD Supplement Side Effects: What Human Studies Actually Show